EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Oxidative stress and its role in Fabry disease

Martina Cacciapuoti, Giovanni Bertoldi, Ilaria Caputo, Giulia Driussi, Gianni Carraro, Lorenzo A Calò iD

Journal of Nephrology · 2024

DOI: 10.1007/s40620-024-01934-7 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Nephrology, 2024. Verfasst von Martina Cacciapuoti und 5 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology, Dialysis and Transplantation Unit, Department of Medicine, University of Padova, Via Giustiniani, 2, 35128, Padua, Italy. Hauptthemen laut MEDLINE: Fabry Disease, Oxidative Stress, Enzyme Replacement Therapy, alpha-Galactosidase. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: University of Padova.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fabry disease is a rare X-linked disease characterized by deficient expression and activity of alpha-galactosidase A with consequent lysosomal accumulation of glycosphingolipids, particularly globotriaosylceramide in various organs. Currently, enzyme replacement therapy with recombinant human α-galactosidase is the cornerstone of the treatment of Fabry patients, although in the long term enzyme replacement therapy fails to halt disease progression, in particular in case of late diagnosis. This suggests that the adverse outcomes cannot be justified by the lysosomal accumulation of glycosphingolipids alone, and that additional therapies targeted at further pathophysiologic mechanisms might contribute to halting the progression of cardiac, cerebrovascular and kidney disease in Fabry patients. Recent evidence points toward the involvement of oxidative stress, oxidative stress signaling and inflammation in the pathophysiology of cardio cerebrovascular and kidney damage in Fabry patients. This review reports the current knowledge of the involvement of oxidative stress in Fabry disease, which clearly points toward the involvement of oxidative stress in the pathophysiology of the medium to long-term cardio-cerebrovascular-kidney damage of Fabry patients and summarizes the antioxidant therapeutic approaches currently available in the literature. This important role played by oxidative stress suggests potential novel additional therapeutic interventions by either pharmacologic or nutritional measures, on top of enzyme replacement therapy, aimed at improving/halting the progression of cardio-cerebrovascular disease and nephropathy that occur in Fabry patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fabry DiseaseOxidative StressEnzyme Replacement Therapyalpha-GalactosidaseHumansAntioxidantsKidney DiseasesAnimalsDisease Progression

Stichwörter der Autor:innen

Antioxidant therapyFabry diseaseOxidative stressOxidative stress signalingTherapy

Substanzen

alpha-GalactosidaseAntioxidants

Autor:innen und Institutionen

  • Nephrology, Dialysis and Transplantation Unit, Department of Medicine, University of Padova, Via Giustiniani, 2, 35128, Padua, Italy.
  • Nephrology, Dialysis and Transplantation Unit, Department of Medicine, University of Padova, Via Giustiniani, 2, 35128, Padua, Italy. renzcalo@unipd.it.

ORCID-Profile: Lorenzo A Calò

Förderung

  • University of Padova

Zitieren

APA

Cacciapuoti, M., Bertoldi, G., Caputo, I., Driussi, G., Carraro, G., & Calò, L. A. (2024). Oxidative stress and its role in Fabry disease. Journal of Nephrology. https://doi.org/10.1007/s40620-024-01934-7

Vancouver

Cacciapuoti M, Bertoldi G, Caputo I, Driussi G, Carraro G, Calò LA. Oxidative stress and its role in Fabry disease. Journal of Nephrology. 2024. doi:10.1007/s40620-024-01934-7

BibTeX
@article{Cacciapuoti2024,
  author = {Cacciapuoti, Martina and Bertoldi, Giovanni and Caputo, Ilaria and Driussi, Giulia and Carraro, Gianni and Calò, Lorenzo A},
  title = {Oxidative stress and its role in Fabry disease},
  journal = {Journal of Nephrology},
  year = {2024},
  doi = {10.1007/s40620-024-01934-7}
}
Kostenlos starten →